FDA Approved: CAPECITABINE — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Capecitabine (CAPECITABINE) from Ascend Laboratories, LLC under ANDA207652.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

SUPPL AP for CAPECITABINE (CAPECITABINE)